Lithium effects: relation to lithium dose and to plasma peak levels

Area of Science:

• Pharmacology
• Psychiatry
• Clinical Chemistry

Background:

• Lithium is a common treatment for manic-melancholic disorders.
• Understanding lithium's effects and optimal dosing is crucial for patient outcomes.
• Nocturnal lithium dosing is a common practice, but its impact on plasma levels and side effects requires investigation.

Purpose of the Study:

• To investigate the relationship between peak plasma lithium levels and various lithium-induced physiological changes in patients with manic-melancholic disorders.
• To determine which lithium-induced changes are correlated with peak plasma lithium levels versus total lithium dose.

Main Methods:

• A 24-hour study was conducted on patients receiving their entire lithium dose at night.
• Plasma peak lithium levels were measured.
• Correlation analysis was performed between plasma lithium levels (peak and dose) and changes in urine volume, weight, plasma phosphate, plasma magnesium, plasma urea, plasma alkaline phosphatase, and urinary pH.

Main Results:

• Peak plasma lithium levels showed significant correlations with decreases in plasma phosphate and increases in urinary pH.
• Increased urine volume was significantly correlated with the total dose of lithium administered.
• No significant correlations were found between peak lithium levels and weight gain, plasma magnesium, plasma urea, or plasma alkaline phosphatase.

Conclusions:

• The study highlights that specific physiological changes, namely plasma phosphate levels and urinary pH, are directly related to peak plasma lithium concentrations.
• Increased urine volume is more closely associated with the overall lithium dose rather than the peak level.
• These findings contribute to a better understanding of lithium pharmacokinetics and pharmacodynamics in managing mood disorders.